Neuroleptics, extrapyramidal symptoms, and serum-calcium levels (Q52091147)

22 April 2018

title

Neuroleptics, extrapyramidal symptoms, and serum-calcium levels (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

15 August 2023

main subject

extrapyramidal symptoms

1 reference

M. H. el-Defrawi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6150808

15 August 2023

T. J. Craig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6150808

15 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6150808

15 August 2023

publication date

1 November 1984

1 reference

22 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0010440X84900348?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

https://api.elsevier.com/content/article/PII:0010440X84900348?httpAccept=text/plain

15 August 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

15 August 2023

published in

Comprehensive Psychiatry

1 reference

22 April 2018

volume

25

1 reference

22 April 2018

issue

6

1 reference

22 April 2018

page(s)

539-545

1 reference

22 April 2018

Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic Schizophrenics

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Comparison of depot fluphenazines: Duration of action and incidence of side effects

15 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

15 August 2023

Q64895699

4

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Motor disorders induced by neuroleptics: a proposed new classification.

15 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Adverse effects of antiparkinsonian drugs

15 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

The pharmacology of choreatic movement disorders

15 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Antiparkinsonian Drugs and Depot Neuroleptics

15 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

The many faces of Akathisia

15 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

A middle ground in prophylactic antiparkinsonian medication

15 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms

15 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Dystonic Reactions to Prochlorperazine in Hypoparathyroidism

15 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase

15 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase

15 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Calcium-dependent cyclic nucleotide phosphodiesterase from brain: Identification of phospholipids as calcium-independent activators

15 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents

15 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Damage of cellular functions by trifluoperazine, a calmodulin-specific drug

15 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

The membrane actions of anesthetics and tranquilizers

15 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Co-operative action a calcium ions in transmitter release at the neuromuscular junction

15 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Calmodulin--an intracellular calcium receptor

15 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

The excitation of spinal neurones by the ionophoretic application of agents which chelate calcium

15 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

A rating scale for extrapyramidal side effects

15 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Extrapyramidal reactions in Asians

15 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Hysteria and drug-induced dystonia

15 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

15 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy

15 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Neuroleptic-associated dysphagia confirmed by esophageal manometry

15 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients

15 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Benztropine prophylaxis of dystonic reactions

15 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Antiparkinson Drug Overuse

15 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis

15 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0010-440X(84)90034-8

15 August 2023

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018